Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazole-Reference-Cited by-同舟云学术

Intracellular binding is an important determinant of the avid hepatic uptake of the high clearance drug omeprazole

Published:1994-08 Issue:4 Volume:48 Page:846-849
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Sewell Richard B.,Brook Christopher W.,Mihaly George W.,Morgan Denis J.,Small-Wood Richard A.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference35 articles.

1. Clearance approaches in pharmacology;Wilkinson;Pharmacol Rev,1987

2. First-pass elimination, basic concepts and clinical consequences;Pond;Clin Pharmacokin,1984

3. The disposition of propranolol IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver;Evans;J Pharmacol Exp Ther,1973

4. Differential effects of hypoxia on the disposition of propranolol and sodium taurocholate by the isolated perfused rat liver;Jones;Hepatology,1982

5. Hepatic uptake of propranolol;Anderson;J Pharmacol Exp Ther,1978

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial Carnitine/Acylcarnitine Translocase: Insights in Structure/ Function Relationships. Basis for Drug Therapy and Side Effects Prediction;Mini-Reviews in Medicinal Chemistry;2015-04-08

2. Prediction of Pharmacokinetic Drug-Drug Interactions Using Human Hepatocyte Suspension in Plasma and Cytochrome P450 Phenotypic Data. III. In Vitro-in Vivo Correlation with Fluconazole;Drug Metabolism and Disposition;2008-04-01

3. QUANTITATIVE PREDICTION OF THE IN VIVO INHIBITION OF DIAZEPAM METABOLISM BY OMEPRAZOLE USING RAT LIVER MICROSOMES AND HEPATOCYTES;Drug Metabolism and Disposition;2004-04-20

4. Evaluation of omeprazole genotoxicity in a battery of in vitro and in vivo assays;Toxicology;1998-09

5. Use of heterologously expressed human cytochrome P4501A2 to predict tacrine-fluvoxamine drug interaction in man;Pharmacogenetics;1998-04